SONG PAUL Y. (Chief Executive Officer) purchased 0.2% of their position (267.95 shares) of NKGEN BIOTECH, INC. on the open market
Open‑market purchase worth $849.95 — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 12/5/2023ACC: 0001209191-23-057370
DirectorOfficer· Chief Executive Officer
Since Sep 2023
+267.95
Net shares
Net buyer
$849.95
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
267.95 acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+162.78
Price / share
$3.07
Trade value
$499.73
% of position
0.1%
12/4/2023
170.70K→170.86K
Common Stock
Direct
Shares
+105.17
Price / share
$3.33
Trade value
$350.22
% of position
0.1%
12/5/2023
170.86K→170.97K
Total
Net shares
+267.95
Net value
$849.95
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/4/2023 | P · Purchase | +162.78 | $3.07 | $499.73 | 0.1% | 170.70K | 170.86K |
| Common Stock Direct | 12/5/2023 | P · Purchase | +105.17 | $3.33 | $350.22 | 0.1% | 170.86K | 170.97K |
| Total | +267.95 | $849.95 | ||||||
Derivative Transactions0
No derivative transactions reported